Previous 10 | Next 10 |
2023-05-06 05:25:23 ET Summary Following the release of Q1 2023 results, MiMedx Group, Inc. shares are soaring on double-digit revenue growth and bottom line on track to turn a profit. MiMedx Group, Inc. is a Marietta, Georgia-based developer and distributor of placental tissue al...
2023-05-03 12:21:19 ET MiMedx ( NASDAQ: MDXG ) stock ~28% on Wednesday after Q1 results beat estimates. Net sales grew +21.7% Y/Y to $71.68M. Meanwhile, net loss narrowed to -$4.98M, compared to -$10.49M in Q1 2022. The company said revenue growth and cost controls helpe...
2023-05-02 23:08:05 ET MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Conference Call May 02, 2023 05:00 PM ET Company Participants Matt Notarianni - Head, IR Joe Capper - CEO Pete Carlson - CFO Conference Call Participants Anthony Petrone - Mizuho Group ...
2023-05-02 16:12:01 ET MiMedx Group press release ( NASDAQ: MDXG ): Q1 GAAP EPS of -$0.06 beats by $0.03 . Revenue of $71.68M (+21.7% Y/Y) beats by $7.53M . The Company continues to believe the business is capable of delivering sales growth in the low double-di...
First Quarter Net Sales of $71.7 Million Reflect an Increase of 21.7% Over the Prior Year Period Revenue Growth & Cost Controls Help Drive Improvements in Net Loss, EBITDA & Adjusted EBITDA 1 Management to Host Conference Call on Tuesday, May&...
2023-05-01 17:35:56 ET MiMedx Group ( NASDAQ: MDXG ) is scheduled to announce Q1 earnings results on Tuesday, May 2nd, after market close. The consensus EPS Estimate is -$0.07 and the consensus Revenue Estimate is $64.15M (+8.9% Y/Y). For further details see: MiM...
MARIETTA, Ga., April 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that it will report operating and financial results for the first quarter ended March 31, 2023 ...
2023-03-23 16:28:35 ET MiMedx ( MDXG ) said Thursday Peter Carlson will step down as the company's chief financial officer. The company has initiated a search for its next CFO. Carlson will be assisting MIMEDX throughout the CFO search process to ensure a smooth trans...
MARIETTA, Ga., March 23, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that Peter M. Carlson, Chief Financial Officer, has decided to leave the Company to pursue othe...
MARIETTA, Ga., March 16, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today applauded the recent report published by OIG entitled, “Some Skin Substitute Manufacturers Did Not...
News, Short Squeeze, Breakout and More Instantly...
Study adds to the Company’s growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM and LHACM allografts on the fibrotic process Marks MIMEDX’s first publication in the 5 th most-cited journal in the world MARIET...
Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...
MARIETTA, Ga., July 17, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2024 after the market close on Wednesday, July 3...